Carmona, S;
Zahs, K;
Wu, E;
Dakin, K;
Bras, J;
Guerreiro, R;
(2018)
The role of TREM2 in Alzheimer's disease and other neurodegenerative disorders.
Lancet Neurology
, 17
(8)
pp. 721-730.
10.1016/S1474-4422(18)30232-1.
Preview |
Text
Louro Guerreiro Carmona_etal_LancetNeurologyJul2018.pdf - Accepted Version Download (785kB) | Preview |
Abstract
Summary Alzheimer's disease is a genetically complex disorder; rare variants in the triggering receptor expressed on myeloid cells 2 (TREM2) gene have been shown to as much as triple an individual's risk of developing Alzheimer's disease. TREM2 is a transmembrane receptor expressed in cells of the myeloid lineage, and its association with Alzheimer's disease supports the involvement of immune and inflammatory pathways in the cause of the disease, rather than as a consequence of the disease. TREM2 variants associated with Alzheimer's disease induce partial loss of function of the TREM2 protein and alter the behaviour of microglial cells, including their response to amyloid plaques. TREM2 variants have also been shown to cause polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy and frontotemporal dementia. Although the low frequency of TREM2 variants makes it difficult to establish robust genotype–phenotype correlations, such studies are essential to enable a comprehensive understanding of the role of TREM2 in different neurological diseases, with the ultimate goal of developing novel therapeutic approaches.
| Type: | Article |
|---|---|
| Title: | The role of TREM2 in Alzheimer's disease and other neurodegenerative disorders |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1016/S1474-4422(18)30232-1 |
| Publisher version: | https://doi.org/10.1016/S1474-4422(18)30232-1 |
| Language: | English |
| Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
| Keywords: | Science & Technology, Life Sciences & Biomedicine, Clinical Neurology, Neurosciences & Neurology, NASU-HAKOLA-DISEASE, AMYOTROPHIC-LATERAL-SCLEROSIS, FLUID SOLUBLE TREM2, BRAIN GENE-EXPRESSION, CELLS 2 TREM2, PARKINSONS-DISEASE, R47H VARIANT, FRONTOTEMPORAL DEMENTIA, RS75932628 ASSOCIATION, MICROGLIAL RESPONSE |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Neurodegenerative Diseases |
| URI: | https://discovery-pp.ucl.ac.uk/id/eprint/10056337 |
Archive Staff Only
 |
View Item |
